Finding – Page 17

Vanqua Bio, VQ-101, Parkinson’s disease, GBA gene mutations, GCase activator, Neurodegenerative diseases, Clinical trials, Lysosomal dysfunction, Alpha-synuclein accumulation

European Medicines Agency Investigates Potential Link Between Hair Loss Drugs and Suicidal Thoughts

11 months ago talkbio0Tagged Agencies, European (ethnic group), Feeling suicidal (finding), finasteride, Hair, Multiple Acyl Coenzyme A Dehydrogenase Deficiency, psychiatric side effects

EMA, hair loss drugs, finasteride, dutasteride, suicidal thoughts, psychiatric side effects, European Medicines Agency

NHS England to Roll Out Eli Lilly’s Obesity Drug Mounjaro in Phased Approach

11 months ago talkbio0Tagged Eli, Eli Lilly, England, Mounjaro, Nance-Horan syndrome, Obesity, Phase, rollout, Weight Loss

NHS England, Eli Lilly, Mounjaro, Obesity Drug, Phased Rollout, Weight Loss, Tirzepatide

Travere Therapeutics Pauses Phase 3 HARMONY Study Due to Manufacturing Scale-Up Challenges

11 months ago talkbio0Tagged Homocystinuria, Manufacture, Pegtibatinase, Phase 3 HARMONY Study, Problem, scale-up

Travere Therapeutics, Phase 3 HARMONY Study, Pegtibatinase, Classical Homocystinuria, Manufacturing Scale-Up Issue

Enanta Pharmaceuticals Achieves Breakthrough in RSV Treatment with EDP-323, Demonstrating Significant Reductions in Viral Load and Symptoms

12 months ago talkbio0Tagged Alleviation, antiviral treatment, EDP-323, Enanta, Human Challenge Study, phase 2a, Respiratory syncytial virus, Symptoms, Viral Load result

Enanta Pharmaceuticals, EDP-323, Respiratory Syncytial Virus (RSV), Antiviral Treatment, Phase 2a Human Challenge Study, Viral Load Reduction, Symptom Alleviation

Wave Life Sciences Reports Positive Interim Data for Duchenne Muscular Dystrophy Treatment

12 months ago talkbio0Tagged Clinical Trials, DMD, Does skip, Duchenne, Dystrophin, exon 53, FORWARD-53, Gene Expression, Interim, Muscular Dystrophy, Muscular Dystrophy, Duchenne, Wave Life Sciences, WVE-N531

Wave Life Sciences, Duchenne Muscular Dystrophy, DMD, Exon 53 Skipping, WVE-N531, FORWARD-53 Clinical Trial, Interim Data, Muscle Health, Dystrophin Expression